Literature DB >> 10486685

Age-related macular degeneration in Chinese-Canadians.

T S Chang1, D Hay, P Courtright.   

Abstract

BACKGROUND: Ethnicity has long been suspected to play a role in the risk of macular degeneration as well as its neovascular complications. We carried out a study to determine the prevalence of retinal diseases in Chinese-Canadians presenting for fluorescein angiography compared to a matched group of Canadians of European origin.
METHODS: We reviewed 20,000 consecutive fluorescein angiograms obtained between December 1987 and November 1993 at a tertiary referral centre for ophthalmic care in Vancouver. All patients identified by name as being of Chinese ancestry were identified and matched to a patient of European ancestry. The two groups were compared in regard to the prevalence of specific retinal diseases, including age-related macular degeneration (AMD).
RESULTS: Among the first 10,000 fluorescein angiograms, 417 patients of Chinese ancestry were identified, of whom 61 (14.6%) had the primary diagnosis of AMD. The rate among the patients of European ancestry was 30.4% (127/417) (odds ratio [OR] 2.12, 95% confidence interval [CI] 1.79 to 2.56) (p < 0.001). A total of 88 ethnic Chinese patients were identified among the subsequent 10,000 angiograms. Pigment epithelial detachments were more than twice as common in the overall group of ethnic Chinese patients as in their counterparts of European ancestry (OR 2.6, 95% CI 0.7 to 10.1). Choroidal neovascularization was 1.6 times more common in the latter group (95% CI 0.98 to 2.8).
INTERPRETATION: The findings support the growing clinical observations of a lower prevalence of AMD in nonwhite populations in addition to an increased prevalence of pigment epithelial detachments in ethnic Chinese patients.

Entities:  

Mesh:

Year:  1999        PMID: 10486685

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  7 in total

1.  Iris melanocyte numbers in Asian, African American, and Caucasian irides.

Authors:  Daniel M Albert; W Richard Green; Michele L Zimbric; Cecilia Lo; Ronald E Gangnon; Kirsten L Hope; Joel Gleiser
Journal:  Trans Am Ophthalmol Soc       Date:  2003

Review 2.  Functional and cortical adaptations to central vision loss.

Authors:  Sing-Hang Cheung; Gordon E Legge
Journal:  Vis Neurosci       Date:  2005 Mar-Apr       Impact factor: 3.241

3.  Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population.

Authors:  Keisuke Mori; Kuniko Horie-Inoue; Masakazu Kohda; Izumi Kawasaki; Peter L Gehlbach; Takuya Awata; Shin Yoneya; Yasushi Okazaki; Satoshi Inoue
Journal:  J Hum Genet       Date:  2007-06-14       Impact factor: 3.172

4.  Association between the SERPING1 gene and age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese.

Authors:  Isao Nakata; Kenji Yamashiro; Ryo Yamada; Norimoto Gotoh; Hideo Nakanishi; Hisako Hayashi; Akitaka Tsujikawa; Atsushi Otani; Masaaki Saito; Tomohiro Iida; Akio Oishi; Keitaro Matsuo; Kazuo Tajima; Fumihiko Matsuda; Nagahisa Yoshimura
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

5.  Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degeneration.

Authors:  Takashi Tsuchihashi; Keisuke Mori; Kuniko Horie-Inoue; Yasushi Okazaki; Takuya Awata; Satoshi Inoue; Shin Yoneya
Journal:  Clin Ophthalmol       Date:  2014-12-05

6.  Estimated prevalence and risk factor for age-related maculopathy.

Authors:  Mi In Roh; Ji Hyun Kim; Suk Ho Byeon; Hyoung Jun Koh; Sung Chul Lee; Oh Woong Kwon
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

7.  TOMM40 rs2075650 polymorphism shows no association with neovascular age-related macular degeneration or polypoidal choroidal vasculopathy in a Chinese population.

Authors:  Jing Guo; Haiping Li; Chunfang Zhang; Yaoyao Sun; Xun Deng; Yujing Bai; Shanshan Li; Min Zhao; Heng Miao; Wenzhen Yu; Bin Wang; Lvzhen Huang; Xiaoxin Li
Journal:  Mol Vis       Date:  2013-09-27       Impact factor: 2.367

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.